Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Archived opportunityLast Updated: May 13, 2026
Important dates
- Archived: April 10, 2026
- Closed: March 7, 2026
Award details
- Expected project funding: $3,000,000
- Expected awards: 6
Award min.
Not specified
Award max.
$500,000
- Funding opportunity number:RFA-DK-26-306
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: December 3, 2025
- Archive date: April 10, 2026
- Version: 1
Summary
Jump to documentsEligibility
Government
- Public and Indian housing authorities
- State governments
- Federally recognized Native American tribal governments
- City or township governments
- County governments
- Special district governments
Miscellaneous
- Other
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-DK-26-306-Full-Announcement.html | RFA-DK-26-306-Full-Announcement.html | Dec 3, 2025 07:54 PM UTC |
Link to additional information
No additional information is available
